Construct Validity of Inherited Retinal Disease-Specific Patient-Reported Outcome Measures.

American journal of ophthalmology(2023)

引用 0|浏览12
暂无评分
摘要
MRDQ and MVAQ domenstrate aspects of construct-validity set forth by the US Food and Drug Administration. The study futher supports the use of both patient-reported outcome measures in IRD clinical trials and natural history studies.NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
更多
查看译文
关键词
inherited retinal disease–specific,patient-reported
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要